Last reviewed · How we verify

NCT04049370

Examination of the Standardized Use of the Pulmonary Embolism SOP in the Clinical Routine of the Emergency Department.

Status unknown Last updated 8 August 2019
What this trial tests

trial testing No intervention in Pulmonary Embolism in 200 participants. Status unknown.

Timeline
1 August 2019
Primary endpoint
31 January 2020
31 January 2020

Quick facts

Lead sponsorHeidelberg University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date1 August 2019
Primary completion31 January 2020
Estimated completion31 January 2020

Drugs / interventions tested

Conditions studied

Sponsor

Heidelberg University

Who can join

18 and older, any sex, with Pulmonary Embolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Usage of a guideline-compliant SOP in each chest pain unit (CPU) is instrumental in establishing the diagnosis of a pulmonary embolism without time delay. With the integration of this SOP as a "clinical decision tool" (CDT) into the electronic database of the CPU, the standardized application of the pulmonary embolism SOP in the clinical routine of the CPU will be tested using a retro- and prospective approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Pulmonary Embolism

Currently open trials in the same condition.

Other Heidelberg University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04049370.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing